StockTipsArenaBeta

BUY Piramal Pharma Limited — Osho Krishan, Angel One

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byOsho Krishan, Angel OneHorizon: NA (inferred 1–3 months)3 Aug 2026via Business Today

Entry₹201.75Inferred
Target₹220
Total upside +9.05% (call closed)
Stop lossNot given
Exit₹22021 Aug 2026, 12:08 pm
Target hit+9.05%0.00%upside left
Follow Osho Krishan for new calls(68% target hit, 50 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 2 active Short-term calls on PPLPHARMASee 44 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Aug 2026
16 supporting5 neutral4 opposing
Supports the BUY call (16)

Yapan Bio to become Piramal subsidiary following acquisition

NewsGoogle News·20 Aug · yesterday

(opens in new tab)

3 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·20 Aug · yesterday

Piramal Pharma Limited has acquired an additional 40.67% stake in Yapan Bio Private Limited for approximately ₹76 crores, increasing its shareholding from 33.33% to 74.00%. Yapan has now become a subs

NSE · Acquisition·18 Aug · 3d ago

(opens in new tab)

Piramal Pharma Ltd has acquired an additional 40.67% stake in Yapan Bio Private Limited for approximately ₹76 crores, increasing its shareholding from 33.33% to 74.00%. Yapan will now become a subsidi

BSE · Company Update·18 Aug · 3d ago

(opens in new tab)

Piramal Pharma Ltd has provided an update regarding the exercise of a call option to acquire an additional equity stake in Yapan Bio Private Limited.

BSE · Company Update·10 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (5)

Piramal Pharma Block Deal: Seller likely to offload 6% stake for around ₹1,750 crore

NewsCnbc-Tv18·13 Aug · 1w ago

(opens in new tab)

Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit

NewsNdtv-Profit·30 Jul · 3w ago

(opens in new tab)

Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·29 Jul · 3w ago

(opens in new tab)

Piramal Pharma temporarily suspends Ahmedabad plant operations due to heavy rainfall

NewsCnbc-Tv18·25 Jul · 4w ago

(opens in new tab)
Weighs against the BUY call (4)

Piramal Pharma block deal likely cancelled; stock falls 3%

NewsCnbc-Tv18·14 Aug · 6d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Osho Krishan, Angel One

Every call and its outcome